	Gene	Drug Name	Mechanism of Action	Drug development phase	Algorithm	GWAS
0	BCL2	ABT-737	BCL inhibitor	Phase 1/Phase 2	DOMINO	GCST004988
1	BCL2	docetaxel	tubulin polymerization inhibitor	Launched	DOMINO	GCST004988
2	BCL2	edaravone	nootropic agent	Launched	DOMINO	GCST004988
3	BCL2	gambogic-acid	caspase activator	Phase 2	DOMINO	GCST004988
4	BCL2	gossypol	BCL inhibitor|MCL1 inhibitor	Phase 2	DOMINO	GCST004988
5	BCL2	HA14-1	BCL inhibitor	Preclinical	DOMINO	GCST004988
6	BCL2	navitoclax	BCL inhibitor	Phase 2	DOMINO	GCST004988
7	BCL2	obatoclax	BCL inhibitor	Phase 3	DOMINO	GCST004988
8	BCL2	oridonin	BCL inhibitor	Preclinical	DOMINO	GCST004988
9	BCL2	paclitaxel	tubulin polymerization inhibitor	Launched	DOMINO	GCST004988
10	BCL2	rasagiline	monoamine oxidase inhibitor	Launched	DOMINO	GCST004988
11	BCL2	TW-37	BCL inhibitor	Preclinical	DOMINO	GCST004988
12	BCL2	venetoclax	BCL inhibitor	Launched	DOMINO	GCST004988
13	ESR1	afimoxifene	estrogen receptor antagonist	Phase 2	DOMINO	GCST004988
14	ESR1	allylestrenol	steroidal progestin	Launched	DOMINO	GCST004988
15	ESR1	AZD9496	estrogen receptor agonist	Phase 1	DOMINO	GCST004988
16	ESR1	bazedoxifene	selective estrogen receptor modulator (SERM)	Launched	DOMINO	GCST004988
17	ESR1	benfluralin		Phase 3	DOMINO	GCST004988
18	ESR1	bisphenol-A	synthetic estrogen	Phase 1	DOMINO	GCST004988
19	ESR1	bithionol	autotaxin inhibitor	Withdrawn	DOMINO	GCST004988
20	ESR1	chlorotrianisene	estrogenic hormone	Launched	DOMINO	GCST004988
21	ESR1	clomifene	estrogen receptor antagonist	Launched	DOMINO	GCST004988
22	ESR1	danazol	estrogen receptor antagonist|progesterone receptor agonist	Launched	DOMINO	GCST004988
23	ESR1	dehydroepiandrosterone	protein synthesis stimulant	Launched	DOMINO	GCST004988
24	ESR1	dehydroepiandrosterone-sulfate	androgen receptor agonist|estrogen receptor agonist	Launched	DOMINO	GCST004988
25	ESR1	desogestrel	progesterone receptor agonist	Launched	DOMINO	GCST004988
26	ESR1	dienestrol	estrogen receptor agonist	Launched	DOMINO	GCST004988
27	ESR1	diethylstilbestrol	estrogen receptor agonist	Withdrawn	DOMINO	GCST004988
28	ESR1	droloxifene	selective estrogen receptor modulator (SERM)	Phase 3	DOMINO	GCST004988
29	ESR1	endoxifen	estrogen receptor antagonist	Phase 2	DOMINO	GCST004988
30	ESR1	equol	estrogen receptor agonist	Launched	DOMINO	GCST004988
31	ESR1	erteberel	estrogen receptor agonist	Phase 2	DOMINO	GCST004988
32	ESR1	estetrol	selective estrogen receptor modulator (SERM)	Phase 3	DOMINO	GCST004988
33	ESR1	estradiol	estrogen receptor agonist	Launched	DOMINO	GCST004988
34	ESR1	estradiol-acetate	estrogen receptor agonist	Launched	DOMINO	GCST004988
35	ESR1	estradiol-benzoate	contraceptive agent	Preclinical	DOMINO	GCST004988
36	ESR1	estradiol-cypionate	estrogen receptor agonist	Launched	DOMINO	GCST004988
37	ESR1	estradiol-valerate	estrogen receptor agonist	Launched	DOMINO	GCST004988
38	ESR1	estramustine	DNA alkylating agent	Launched	DOMINO	GCST004988
39	ESR1	estramustine-phosphate	DNA synthesis inhibitor|microtubule inhibitor	Launched	DOMINO	GCST004988
40	ESR1	estriol	estrogen receptor agonist	Launched	DOMINO	GCST004988
41	ESR1	estrone	estrogen receptor agonist|estrogenic hormone	Launched	DOMINO	GCST004988
42	ESR1	estropipate	estrogen receptor agonist	Launched	DOMINO	GCST004988
43	ESR1	ethinyl-estradiol	estrogen receptor agonist|estrogenic hormone	Launched	DOMINO	GCST004988
44	ESR1	ethynodiol-diacetate		Launched	DOMINO	GCST004988
45	ESR1	etonogestrel	progesterone receptor agonist	Launched	DOMINO	GCST004988
46	ESR1	fosfestrol	synthetic estrogen	Launched	DOMINO	GCST004988
47	ESR1	fulvestrant	estrogen receptor antagonist	Launched	DOMINO	GCST004988
48	ESR1	GDC-0810	selective estrogen receptor destabilizer	Phase 2	DOMINO	GCST004988
49	ESR1	genistein	tyrosine kinase inhibitor	Phase 2/Phase 3	DOMINO	GCST004988
50	ESR1	gestrinone	progesterone receptor antagonist	Launched	DOMINO	GCST004988
51	ESR1	hexestrol	synthetic estrogen	Launched	DOMINO	GCST004988
52	ESR1	lasofoxifene	selective estrogen receptor modulator (SERM)	Launched	DOMINO	GCST004988
53	ESR1	medroxyprogesterone-acetate	progesterone receptor agonist	Launched	DOMINO	GCST004988
54	ESR1	melatonin	melatonin receptor agonist|nitric oxide synthase inhibitor	Launched	DOMINO	GCST004988
55	ESR1	mestranol	estrogen receptor agonist	Launched	DOMINO	GCST004988
56	ESR1	mitotane	antineoplastic agent	Launched	DOMINO	GCST004988
57	ESR1	naloxone	opioid receptor antagonist	Launched	DOMINO	GCST004988
58	ESR1	norgestimate	progesterone receptor agonist	Launched	DOMINO	GCST004988
59	ESR1	norgestrel	progesterone receptor agonist	Launched	DOMINO	GCST004988
60	ESR1	ospemifene	selective estrogen receptor modulator (SERM)	Launched	DOMINO	GCST004988
61	ESR1	PPT	estrogen receptor agonist	Preclinical	DOMINO	GCST004988
62	ESR1	progesterone	progesterone receptor agonist	Launched	DOMINO	GCST004988
63	ESR1	promestriene	estrogen receptor agonist	Launched	DOMINO	GCST004988
64	ESR1	quinestrol	estrogen receptor agonist	Launched	DOMINO	GCST004988
65	ESR1	raloxifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	DOMINO	GCST004988
66	ESR1	SNG-1153	selective estrogen receptor modulator (SERM)	Preclinical	DOMINO	GCST004988
67	ESR1	tamoxifen	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	DOMINO	GCST004988
68	ESR1	tibolone	androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist	Launched	DOMINO	GCST004988
69	ESR1	toremifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	DOMINO	GCST004988
70	ESR1	Y-134	estrogen receptor antagonist	Preclinical	DOMINO	GCST004988
71	ESR1	ZK-164015	estrogen receptor antagonist	Preclinical	DOMINO	GCST004988
72	ESR1	17-hydroxyprogesterone-caproate	progesterone receptor agonist	Launched	DOMINO	GCST004988
73	RRM2	cladribine	adenosine deaminase inhibitor|ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST004988
74	RRM2	clofarabine	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST004988
75	RRM2	fludarabine	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST004988
76	RRM2	fludarabine-phosphate	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST004988
77	RRM2	gemcitabine	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST004988
78	RRM2	hydroxyurea	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST004988
79	RRM2	triapine	ribonucleotide reductase inhibitor	Phase 2	RMM-GWAS	GCST004988
80	EGFR	AEE788	EGFR inhibitor|VEGFR inhibitor	Phase 1/Phase 2	RMM-GWAS	GCST004988
81	EGFR	afatinib	EGFR inhibitor	Launched	RMM-GWAS	GCST004988
82	EGFR	AG-490	EGFR inhibitor|JAK inhibitor	Preclinical	RMM-GWAS	GCST004988
83	EGFR	alvocidib	CDK inhibitor	Phase 2	RMM-GWAS	GCST004988
84	EGFR	AP26113	ALK tyrosine kinase receptor inhibitor	Phase 2	RMM-GWAS	GCST004988
85	EGFR	AST-1306	EGFR inhibitor	Phase 1	RMM-GWAS	GCST004988
86	EGFR	AV-412	protein tyrosine kinase inhibitor	Phase 1	RMM-GWAS	GCST004988
87	EGFR	AZD3759	EGFR inhibitor	Phase 2/Phase 3	RMM-GWAS	GCST004988
88	EGFR	AZD8931	EGFR inhibitor	Phase 2	RMM-GWAS	GCST004988
89	EGFR	AZ5104	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
90	EGFR	BIBU-1361	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
91	EGFR	BIBX-1382	EGFR inhibitor	Phase 1	RMM-GWAS	GCST004988
92	EGFR	BMS-599626	EGFR inhibitor|protein tyrosine kinase inhibitor	Phase 1	RMM-GWAS	GCST004988
93	EGFR	BMS-690514	EGFR inhibitor|VEGFR inhibitor	Phase 2	RMM-GWAS	GCST004988
94	EGFR	brigatinib	ALK tyrosine kinase receptor inhibitor|EGFR inhibitor	Launched	RMM-GWAS	GCST004988
95	EGFR	canertinib	EGFR inhibitor	Phase 3	RMM-GWAS	GCST004988
96	EGFR	CGP-52411	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
97	EGFR	CGP-53353	EGFR inhibitor|PKC inhibitor	Preclinical	RMM-GWAS	GCST004988
98	EGFR	chrysophanic-acid	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
99	EGFR	CNX-2006	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
100	EGFR	CUDC-101	EGFR inhibitor	Phase 1	RMM-GWAS	GCST004988
101	EGFR	dacomitinib	EGFR inhibitor	Launched	RMM-GWAS	GCST004988
102	EGFR	dovitinib	EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Phase 3	RMM-GWAS	GCST004988
103	EGFR	EGF816	EGFR inhibitor	Phase 2	RMM-GWAS	GCST004988
104	EGFR	erbstatin-analog	EGFR inhibitor|tyrosine kinase inhibitor	Preclinical	RMM-GWAS	GCST004988
105	EGFR	erlotinib	EGFR inhibitor	Launched	RMM-GWAS	GCST004988
106	EGFR	gefitinib	EGFR inhibitor	Launched	RMM-GWAS	GCST004988
107	EGFR	GW-583340	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
108	EGFR	HKI-357	EGFR inhibitor	Phase 1	RMM-GWAS	GCST004988
109	EGFR	icotinib	EGFR inhibitor	Launched	RMM-GWAS	GCST004988
110	EGFR	lapatinib	EGFR inhibitor	Launched	RMM-GWAS	GCST004988
111	EGFR	lidocaine	histamine receptor agonist	Launched	RMM-GWAS	GCST004988
112	EGFR	mubritinib	protein tyrosine kinase inhibitor	Phase 1	RMM-GWAS	GCST004988
113	EGFR	neratinib	EGFR inhibitor	Launched	RMM-GWAS	GCST004988
114	EGFR	olmutinib	Bruton's tyrosine kinase (BTK) inhibitor|EGFR inhibitor	Launched	RMM-GWAS	GCST004988
115	EGFR	orantinib	FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Phase 3	RMM-GWAS	GCST004988
116	EGFR	OSI-420	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
117	EGFR	osimertinib	EGFR inhibitor	Launched	RMM-GWAS	GCST004988
118	EGFR	PD-153035	EGFR inhibitor	Phase 1	RMM-GWAS	GCST004988
119	EGFR	PD-158780	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
120	EGFR	PD-166285	SRC inhibitor	Preclinical	RMM-GWAS	GCST004988
121	EGFR	PD-168393	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
122	EGFR	pelitinib	EGFR inhibitor	Phase 2	RMM-GWAS	GCST004988
123	EGFR	PKI-166	EGFR inhibitor	Phase 1	RMM-GWAS	GCST004988
124	EGFR	poziotinib	EGFR inhibitor	Phase 2	RMM-GWAS	GCST004988
125	EGFR	PP-121	protein tyrosine kinase inhibitor	Preclinical	RMM-GWAS	GCST004988
126	EGFR	rociletinib	EGFR inhibitor	Phase 3	RMM-GWAS	GCST004988
127	EGFR	tyrphostin-AG-1478	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
128	EGFR	tyrphostin-AG-18	EGFR inhibitor|tyrosine kinase inhibitor	Preclinical	RMM-GWAS	GCST004988
129	EGFR	tyrphostin-AG-494	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
130	EGFR	tyrphostin-AG-835	protein tyrosine kinase inhibitor	Preclinical	RMM-GWAS	GCST004988
131	EGFR	tyrphostin-AG-99	tyrosine kinase inhibitor	Preclinical	RMM-GWAS	GCST004988
132	EGFR	vandetanib	EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	Launched	RMM-GWAS	GCST004988
133	EGFR	vatalanib	KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Phase 3	RMM-GWAS	GCST004988
134	EGFR	WHI-P154	JAK inhibitor	Preclinical	RMM-GWAS	GCST004988
135	EGFR	WZ-3146	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
136	EGFR	WZ-4002	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
137	EGFR	WZ8040	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
138	EGFR	XL647	EGFR inhibitor|VEGFR inhibitor	Phase 3	RMM-GWAS	GCST004988
139	EGFR	ZM-306416	Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
140	ATIC	pemetrexed	dihydrofolate reductase inhibitor|thymidylate synthase inhibitor	Launched	RMM-GWAS	GCST004988
141	CDK6	abemaciclib	CDK inhibitor	Launched	RMM-GWAS	GCST004988
142	CDK6	alvocidib	CDK inhibitor	Phase 2	RMM-GWAS	GCST004988
143	CDK6	AMG-925	CDK inhibitor|FLT3 inhibitor	Phase 1	RMM-GWAS	GCST004988
144	CDK6	apigenin	casein kinase inhibitor|cell proliferation inhibitor	Preclinical	RMM-GWAS	GCST004988
145	CDK6	AT-7519	CDK inhibitor	Phase 2	RMM-GWAS	GCST004988
146	CDK6	chrysin	breast cancer resistance protein inhibitor	Phase 1	RMM-GWAS	GCST004988
147	CDK6	fisetin	Aurora kinase inhibitor	Preclinical	RMM-GWAS	GCST004988
148	CDK6	palbociclib	CDK inhibitor	Launched	RMM-GWAS	GCST004988
149	CDK6	RGB-286638	CDK inhibitor	Phase 1	RMM-GWAS	GCST004988
150	CDK6	ribociclib	CDK inhibitor	Launched	RMM-GWAS	GCST004988
151	ESR1	afimoxifene	estrogen receptor antagonist	Phase 2	RMM-GWAS	GCST004988
152	ESR1	allylestrenol	steroidal progestin	Launched	RMM-GWAS	GCST004988
153	ESR1	AZD9496	estrogen receptor agonist	Phase 1	RMM-GWAS	GCST004988
154	ESR1	bazedoxifene	selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST004988
155	ESR1	benfluralin		Phase 3	RMM-GWAS	GCST004988
156	ESR1	bisphenol-A	synthetic estrogen	Phase 1	RMM-GWAS	GCST004988
157	ESR1	bithionol	autotaxin inhibitor	Withdrawn	RMM-GWAS	GCST004988
158	ESR1	chlorotrianisene	estrogenic hormone	Launched	RMM-GWAS	GCST004988
159	ESR1	clomifene	estrogen receptor antagonist	Launched	RMM-GWAS	GCST004988
160	ESR1	danazol	estrogen receptor antagonist|progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
161	ESR1	dehydroepiandrosterone	protein synthesis stimulant	Launched	RMM-GWAS	GCST004988
162	ESR1	dehydroepiandrosterone-sulfate	androgen receptor agonist|estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
163	ESR1	desogestrel	progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
164	ESR1	dienestrol	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
165	ESR1	diethylstilbestrol	estrogen receptor agonist	Withdrawn	RMM-GWAS	GCST004988
166	ESR1	droloxifene	selective estrogen receptor modulator (SERM)	Phase 3	RMM-GWAS	GCST004988
167	ESR1	endoxifen	estrogen receptor antagonist	Phase 2	RMM-GWAS	GCST004988
168	ESR1	equol	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
169	ESR1	erteberel	estrogen receptor agonist	Phase 2	RMM-GWAS	GCST004988
170	ESR1	estetrol	selective estrogen receptor modulator (SERM)	Phase 3	RMM-GWAS	GCST004988
171	ESR1	estradiol	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
172	ESR1	estradiol-acetate	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
173	ESR1	estradiol-benzoate	contraceptive agent	Preclinical	RMM-GWAS	GCST004988
174	ESR1	estradiol-cypionate	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
175	ESR1	estradiol-valerate	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
176	ESR1	estramustine	DNA alkylating agent	Launched	RMM-GWAS	GCST004988
177	ESR1	estramustine-phosphate	DNA synthesis inhibitor|microtubule inhibitor	Launched	RMM-GWAS	GCST004988
178	ESR1	estriol	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
179	ESR1	estrone	estrogen receptor agonist|estrogenic hormone	Launched	RMM-GWAS	GCST004988
180	ESR1	estropipate	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
181	ESR1	ethinyl-estradiol	estrogen receptor agonist|estrogenic hormone	Launched	RMM-GWAS	GCST004988
182	ESR1	ethynodiol-diacetate		Launched	RMM-GWAS	GCST004988
183	ESR1	etonogestrel	progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
184	ESR1	fosfestrol	synthetic estrogen	Launched	RMM-GWAS	GCST004988
185	ESR1	fulvestrant	estrogen receptor antagonist	Launched	RMM-GWAS	GCST004988
186	ESR1	GDC-0810	selective estrogen receptor destabilizer	Phase 2	RMM-GWAS	GCST004988
187	ESR1	genistein	tyrosine kinase inhibitor	Phase 2/Phase 3	RMM-GWAS	GCST004988
188	ESR1	gestrinone	progesterone receptor antagonist	Launched	RMM-GWAS	GCST004988
189	ESR1	hexestrol	synthetic estrogen	Launched	RMM-GWAS	GCST004988
190	ESR1	lasofoxifene	selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST004988
191	ESR1	medroxyprogesterone-acetate	progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
192	ESR1	melatonin	melatonin receptor agonist|nitric oxide synthase inhibitor	Launched	RMM-GWAS	GCST004988
193	ESR1	mestranol	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
194	ESR1	mitotane	antineoplastic agent	Launched	RMM-GWAS	GCST004988
195	ESR1	naloxone	opioid receptor antagonist	Launched	RMM-GWAS	GCST004988
196	ESR1	norgestimate	progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
197	ESR1	norgestrel	progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
198	ESR1	ospemifene	selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST004988
199	ESR1	PPT	estrogen receptor agonist	Preclinical	RMM-GWAS	GCST004988
200	ESR1	progesterone	progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
201	ESR1	promestriene	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
202	ESR1	quinestrol	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
203	ESR1	raloxifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST004988
204	ESR1	SNG-1153	selective estrogen receptor modulator (SERM)	Preclinical	RMM-GWAS	GCST004988
205	ESR1	tamoxifen	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST004988
206	ESR1	tibolone	androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
207	ESR1	toremifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST004988
208	ESR1	Y-134	estrogen receptor antagonist	Preclinical	RMM-GWAS	GCST004988
209	ESR1	ZK-164015	estrogen receptor antagonist	Preclinical	RMM-GWAS	GCST004988
210	ESR1	17-hydroxyprogesterone-caproate	progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
211	EPHA5	vandetanib	EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	Launched	RMM-GWAS	GCST004988
212	ESR1	afimoxifene	estrogen receptor antagonist	Phase 2	SIGMOID	GCST004988
213	ESR1	allylestrenol	steroidal progestin	Launched	SIGMOID	GCST004988
214	ESR1	AZD9496	estrogen receptor agonist	Phase 1	SIGMOID	GCST004988
215	ESR1	bazedoxifene	selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
216	ESR1	benfluralin		Phase 3	SIGMOID	GCST004988
217	ESR1	bisphenol-A	synthetic estrogen	Phase 1	SIGMOID	GCST004988
218	ESR1	bithionol	autotaxin inhibitor	Withdrawn	SIGMOID	GCST004988
219	ESR1	chlorotrianisene	estrogenic hormone	Launched	SIGMOID	GCST004988
220	ESR1	clomifene	estrogen receptor antagonist	Launched	SIGMOID	GCST004988
221	ESR1	danazol	estrogen receptor antagonist|progesterone receptor agonist	Launched	SIGMOID	GCST004988
222	ESR1	dehydroepiandrosterone	protein synthesis stimulant	Launched	SIGMOID	GCST004988
223	ESR1	dehydroepiandrosterone-sulfate	androgen receptor agonist|estrogen receptor agonist	Launched	SIGMOID	GCST004988
224	ESR1	desogestrel	progesterone receptor agonist	Launched	SIGMOID	GCST004988
225	ESR1	dienestrol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
226	ESR1	diethylstilbestrol	estrogen receptor agonist	Withdrawn	SIGMOID	GCST004988
227	ESR1	droloxifene	selective estrogen receptor modulator (SERM)	Phase 3	SIGMOID	GCST004988
228	ESR1	endoxifen	estrogen receptor antagonist	Phase 2	SIGMOID	GCST004988
229	ESR1	equol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
230	ESR1	erteberel	estrogen receptor agonist	Phase 2	SIGMOID	GCST004988
231	ESR1	estetrol	selective estrogen receptor modulator (SERM)	Phase 3	SIGMOID	GCST004988
232	ESR1	estradiol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
233	ESR1	estradiol-acetate	estrogen receptor agonist	Launched	SIGMOID	GCST004988
234	ESR1	estradiol-benzoate	contraceptive agent	Preclinical	SIGMOID	GCST004988
235	ESR1	estradiol-cypionate	estrogen receptor agonist	Launched	SIGMOID	GCST004988
236	ESR1	estradiol-valerate	estrogen receptor agonist	Launched	SIGMOID	GCST004988
237	ESR1	estramustine	DNA alkylating agent	Launched	SIGMOID	GCST004988
238	ESR1	estramustine-phosphate	DNA synthesis inhibitor|microtubule inhibitor	Launched	SIGMOID	GCST004988
239	ESR1	estriol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
240	ESR1	estrone	estrogen receptor agonist|estrogenic hormone	Launched	SIGMOID	GCST004988
241	ESR1	estropipate	estrogen receptor agonist	Launched	SIGMOID	GCST004988
242	ESR1	ethinyl-estradiol	estrogen receptor agonist|estrogenic hormone	Launched	SIGMOID	GCST004988
243	ESR1	ethynodiol-diacetate		Launched	SIGMOID	GCST004988
244	ESR1	etonogestrel	progesterone receptor agonist	Launched	SIGMOID	GCST004988
245	ESR1	fosfestrol	synthetic estrogen	Launched	SIGMOID	GCST004988
246	ESR1	fulvestrant	estrogen receptor antagonist	Launched	SIGMOID	GCST004988
247	ESR1	GDC-0810	selective estrogen receptor destabilizer	Phase 2	SIGMOID	GCST004988
248	ESR1	genistein	tyrosine kinase inhibitor	Phase 2/Phase 3	SIGMOID	GCST004988
249	ESR1	gestrinone	progesterone receptor antagonist	Launched	SIGMOID	GCST004988
250	ESR1	hexestrol	synthetic estrogen	Launched	SIGMOID	GCST004988
251	ESR1	lasofoxifene	selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
252	ESR1	medroxyprogesterone-acetate	progesterone receptor agonist	Launched	SIGMOID	GCST004988
253	ESR1	melatonin	melatonin receptor agonist|nitric oxide synthase inhibitor	Launched	SIGMOID	GCST004988
254	ESR1	mestranol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
255	ESR1	mitotane	antineoplastic agent	Launched	SIGMOID	GCST004988
256	ESR1	naloxone	opioid receptor antagonist	Launched	SIGMOID	GCST004988
257	ESR1	norgestimate	progesterone receptor agonist	Launched	SIGMOID	GCST004988
258	ESR1	norgestrel	progesterone receptor agonist	Launched	SIGMOID	GCST004988
259	ESR1	ospemifene	selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
260	ESR1	PPT	estrogen receptor agonist	Preclinical	SIGMOID	GCST004988
261	ESR1	progesterone	progesterone receptor agonist	Launched	SIGMOID	GCST004988
262	ESR1	promestriene	estrogen receptor agonist	Launched	SIGMOID	GCST004988
263	ESR1	quinestrol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
264	ESR1	raloxifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
265	ESR1	SNG-1153	selective estrogen receptor modulator (SERM)	Preclinical	SIGMOID	GCST004988
266	ESR1	tamoxifen	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
267	ESR1	tibolone	androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist	Launched	SIGMOID	GCST004988
268	ESR1	toremifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
269	ESR1	Y-134	estrogen receptor antagonist	Preclinical	SIGMOID	GCST004988
270	ESR1	ZK-164015	estrogen receptor antagonist	Preclinical	SIGMOID	GCST004988
271	ESR1	17-hydroxyprogesterone-caproate	progesterone receptor agonist	Launched	SIGMOID	GCST004988
272	CYP2A6	coumarin	vitamin K antagonist	Launched	DOMINO	GCST004748
273	CYP2A6	cyclophosphamide	DNA alkylating agent	Launched	DOMINO	GCST004748
274	CYP2A6	ifosfamide	DNA alkylating agent	Launched	DOMINO	GCST004748
275	CYP2A6	methoxsalen	DNA synthesis inhibitor	Launched	DOMINO	GCST004748
276	CYP2A6	nevirapine	non-nucleoside reverse transcriptase inhibitor	Launched	DOMINO	GCST004748
277	FRK	bosutinib	Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor	Launched	RMM-GWAS	GCST004748
278	FRK	dasatinib	Bcr-Abl kinase inhibitor|ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor|tyrosine kinase inhibitor	Launched	RMM-GWAS	GCST004748
279	FRK	regorafenib	FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	Launched	RMM-GWAS	GCST004748
280	TLR4	C34	toll-like receptor inhibitor	Preclinical	RMM-GWAS	GCST004748
281	TLR4	lauric-acid	bacterial permeability inducer	Phase 3	RMM-GWAS	GCST004748
282	TLR4	naloxone	opioid receptor antagonist	Launched	RMM-GWAS	GCST004748
283	TLR4	paclitaxel	tubulin polymerization inhibitor	Launched	RMM-GWAS	GCST004748
284	TLR4	resatorvid	toll-like receptor inhibitor	Phase 3	RMM-GWAS	GCST004748
285	TLR4	VGX-1027	tumor necrosis factor receptor antagonist	Phase 1	RMM-GWAS	GCST004748
286	EPHA5	vandetanib	EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	Launched	RMM-GWAS	GCST004748
287	CYP2A6	coumarin	vitamin K antagonist	Launched	DOMINO	GCST004749
288	CYP2A6	cyclophosphamide	DNA alkylating agent	Launched	DOMINO	GCST004749
289	CYP2A6	ifosfamide	DNA alkylating agent	Launched	DOMINO	GCST004749
290	CYP2A6	methoxsalen	DNA synthesis inhibitor	Launched	DOMINO	GCST004749
291	CYP2A6	nevirapine	non-nucleoside reverse transcriptase inhibitor	Launched	DOMINO	GCST004749
292	AHR	atorvastatin	HMGCR inhibitor	Launched	DOMINO	GCST004749
293	AHR	CH223191	aryl hydrocarbon receptor antagonist	Preclinical	DOMINO	GCST004749
294	AHR	diosmin	aryl hydrocarbon receptor agonist|capillary stabilizing agent	Launched	DOMINO	GCST004749
295	AHR	flutamide	androgen receptor antagonist	Launched	DOMINO	GCST004749
296	AHR	indole-3-carbinol	aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor	Phase 2/Phase 3	DOMINO	GCST004749
297	AHR	ITE	aryl hydrocarbon receptor agonist	Preclinical	DOMINO	GCST004749
298	AHR	leflunomide	dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor	Launched	DOMINO	GCST004749
299	AHR	phortress	aryl hydrocarbon receptor ligand	Phase 1	DOMINO	GCST004749
300	AHR	stemregenin-1	aryl hydrocarbon receptor antagonist	Preclinical	DOMINO	GCST004749
301	LHCGR	cetrorelix	gonadotropin releasing factor hormone receptor antagonist	Launched	RMM-GWAS	GCST004749
302	LHCGR	goserelin-acetate	gonadotropin releasing factor hormone receptor agonist	Launched	RMM-GWAS	GCST004749
303	ESR1	afimoxifene	estrogen receptor antagonist	Phase 2	DOMINO	GCST90090980
304	ESR1	allylestrenol	steroidal progestin	Launched	DOMINO	GCST90090980
305	ESR1	AZD9496	estrogen receptor agonist	Phase 1	DOMINO	GCST90090980
306	ESR1	bazedoxifene	selective estrogen receptor modulator (SERM)	Launched	DOMINO	GCST90090980
307	ESR1	benfluralin		Phase 3	DOMINO	GCST90090980
308	ESR1	bisphenol-A	synthetic estrogen	Phase 1	DOMINO	GCST90090980
309	ESR1	bithionol	autotaxin inhibitor	Withdrawn	DOMINO	GCST90090980
310	ESR1	chlorotrianisene	estrogenic hormone	Launched	DOMINO	GCST90090980
311	ESR1	clomifene	estrogen receptor antagonist	Launched	DOMINO	GCST90090980
312	ESR1	danazol	estrogen receptor antagonist|progesterone receptor agonist	Launched	DOMINO	GCST90090980
313	ESR1	dehydroepiandrosterone	protein synthesis stimulant	Launched	DOMINO	GCST90090980
314	ESR1	dehydroepiandrosterone-sulfate	androgen receptor agonist|estrogen receptor agonist	Launched	DOMINO	GCST90090980
315	ESR1	desogestrel	progesterone receptor agonist	Launched	DOMINO	GCST90090980
316	ESR1	dienestrol	estrogen receptor agonist	Launched	DOMINO	GCST90090980
317	ESR1	diethylstilbestrol	estrogen receptor agonist	Withdrawn	DOMINO	GCST90090980
318	ESR1	droloxifene	selective estrogen receptor modulator (SERM)	Phase 3	DOMINO	GCST90090980
319	ESR1	endoxifen	estrogen receptor antagonist	Phase 2	DOMINO	GCST90090980
320	ESR1	equol	estrogen receptor agonist	Launched	DOMINO	GCST90090980
321	ESR1	erteberel	estrogen receptor agonist	Phase 2	DOMINO	GCST90090980
322	ESR1	estetrol	selective estrogen receptor modulator (SERM)	Phase 3	DOMINO	GCST90090980
323	ESR1	estradiol	estrogen receptor agonist	Launched	DOMINO	GCST90090980
324	ESR1	estradiol-acetate	estrogen receptor agonist	Launched	DOMINO	GCST90090980
325	ESR1	estradiol-benzoate	contraceptive agent	Preclinical	DOMINO	GCST90090980
326	ESR1	estradiol-cypionate	estrogen receptor agonist	Launched	DOMINO	GCST90090980
327	ESR1	estradiol-valerate	estrogen receptor agonist	Launched	DOMINO	GCST90090980
328	ESR1	estramustine	DNA alkylating agent	Launched	DOMINO	GCST90090980
329	ESR1	estramustine-phosphate	DNA synthesis inhibitor|microtubule inhibitor	Launched	DOMINO	GCST90090980
330	ESR1	estriol	estrogen receptor agonist	Launched	DOMINO	GCST90090980
331	ESR1	estrone	estrogen receptor agonist|estrogenic hormone	Launched	DOMINO	GCST90090980
332	ESR1	estropipate	estrogen receptor agonist	Launched	DOMINO	GCST90090980
333	ESR1	ethinyl-estradiol	estrogen receptor agonist|estrogenic hormone	Launched	DOMINO	GCST90090980
334	ESR1	ethynodiol-diacetate		Launched	DOMINO	GCST90090980
335	ESR1	etonogestrel	progesterone receptor agonist	Launched	DOMINO	GCST90090980
336	ESR1	fosfestrol	synthetic estrogen	Launched	DOMINO	GCST90090980
337	ESR1	fulvestrant	estrogen receptor antagonist	Launched	DOMINO	GCST90090980
338	ESR1	GDC-0810	selective estrogen receptor destabilizer	Phase 2	DOMINO	GCST90090980
339	ESR1	genistein	tyrosine kinase inhibitor	Phase 2/Phase 3	DOMINO	GCST90090980
340	ESR1	gestrinone	progesterone receptor antagonist	Launched	DOMINO	GCST90090980
341	ESR1	hexestrol	synthetic estrogen	Launched	DOMINO	GCST90090980
342	ESR1	lasofoxifene	selective estrogen receptor modulator (SERM)	Launched	DOMINO	GCST90090980
343	ESR1	medroxyprogesterone-acetate	progesterone receptor agonist	Launched	DOMINO	GCST90090980
344	ESR1	melatonin	melatonin receptor agonist|nitric oxide synthase inhibitor	Launched	DOMINO	GCST90090980
345	ESR1	mestranol	estrogen receptor agonist	Launched	DOMINO	GCST90090980
346	ESR1	mitotane	antineoplastic agent	Launched	DOMINO	GCST90090980
347	ESR1	naloxone	opioid receptor antagonist	Launched	DOMINO	GCST90090980
348	ESR1	norgestimate	progesterone receptor agonist	Launched	DOMINO	GCST90090980
349	ESR1	norgestrel	progesterone receptor agonist	Launched	DOMINO	GCST90090980
350	ESR1	ospemifene	selective estrogen receptor modulator (SERM)	Launched	DOMINO	GCST90090980
351	ESR1	PPT	estrogen receptor agonist	Preclinical	DOMINO	GCST90090980
352	ESR1	progesterone	progesterone receptor agonist	Launched	DOMINO	GCST90090980
353	ESR1	promestriene	estrogen receptor agonist	Launched	DOMINO	GCST90090980
354	ESR1	quinestrol	estrogen receptor agonist	Launched	DOMINO	GCST90090980
355	ESR1	raloxifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	DOMINO	GCST90090980
356	ESR1	SNG-1153	selective estrogen receptor modulator (SERM)	Preclinical	DOMINO	GCST90090980
357	ESR1	tamoxifen	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	DOMINO	GCST90090980
358	ESR1	tibolone	androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist	Launched	DOMINO	GCST90090980
359	ESR1	toremifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	DOMINO	GCST90090980
360	ESR1	Y-134	estrogen receptor antagonist	Preclinical	DOMINO	GCST90090980
361	ESR1	ZK-164015	estrogen receptor antagonist	Preclinical	DOMINO	GCST90090980
362	ESR1	17-hydroxyprogesterone-caproate	progesterone receptor agonist	Launched	DOMINO	GCST90090980
363	MTOR	AP1903		Phase 1/Phase 2	RMM-GWAS	GCST90090980
364	MTOR	AZD2014	mTOR inhibitor	Phase 2	RMM-GWAS	GCST90090980
365	MTOR	AZD8055	mTOR inhibitor	Phase 1	RMM-GWAS	GCST90090980
366	MTOR	AZ20	ATR kinase inhibitor	Preclinical	RMM-GWAS	GCST90090980
367	MTOR	beta-hydroxy-beta-methylbutyrate	protein synthesis stimulant	Launched	RMM-GWAS	GCST90090980
368	MTOR	BGT226	PI3K inhibitor	Phase 1/Phase 2	RMM-GWAS	GCST90090980
369	MTOR	CC-115	DNA protein kinase inhibitor|mTOR inhibitor	Phase 2	RMM-GWAS	GCST90090980
370	MTOR	CC-223	mTOR inhibitor	Phase 2	RMM-GWAS	GCST90090980
371	MTOR	chrysophanic-acid	EGFR inhibitor	Preclinical	RMM-GWAS	GCST90090980
372	MTOR	CH5132799	PI3K inhibitor	Phase 1	RMM-GWAS	GCST90090980
373	MTOR	compound-401	DNA dependent protein kinase inhibitor	Preclinical	RMM-GWAS	GCST90090980
374	MTOR	deforolimus	mTOR inhibitor	Phase 3	RMM-GWAS	GCST90090980
375	MTOR	everolimus	mTOR inhibitor	Launched	RMM-GWAS	GCST90090980
376	MTOR	GDC-0980	mTOR inhibitor|PI3K inhibitor	Phase 2	RMM-GWAS	GCST90090980
377	MTOR	GSK2126458	mTOR inhibitor|PI3K inhibitor	Phase 1	RMM-GWAS	GCST90090980
378	MTOR	KU-0063794	mTOR inhibitor	Preclinical	RMM-GWAS	GCST90090980
379	MTOR	LY294002	DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor	Preclinical	RMM-GWAS	GCST90090980
380	MTOR	LY3023414	mTOR inhibitor|PI3K inhibitor	Phase 2	RMM-GWAS	GCST90090980
381	MTOR	MLN0128	mTOR inhibitor	Phase 2	RMM-GWAS	GCST90090980
382	MTOR	NVP-BEZ235	mTOR inhibitor|PI3K inhibitor	Phase 3	RMM-GWAS	GCST90090980
383	MTOR	OSI-027	mTOR inhibitor	Phase 1	RMM-GWAS	GCST90090980
384	MTOR	palomid-529	AKT inhibitor|mTOR inhibitor	Phase 1	RMM-GWAS	GCST90090980
385	MTOR	PF-04691502	mTOR inhibitor|PI3K inhibitor	Phase 2	RMM-GWAS	GCST90090980
386	MTOR	PF-05212384	mTOR inhibitor|PI3K inhibitor	Phase 2	RMM-GWAS	GCST90090980
387	MTOR	PI-103	mTOR inhibitor|PI3K inhibitor	Preclinical	RMM-GWAS	GCST90090980
388	MTOR	PKI-179	mTOR inhibitor|PI3K inhibitor	Phase 1	RMM-GWAS	GCST90090980
389	MTOR	PP-121	protein tyrosine kinase inhibitor	Preclinical	RMM-GWAS	GCST90090980
390	MTOR	PP242	mTOR inhibitor	Preclinical	RMM-GWAS	GCST90090980
391	MTOR	SAR-245409	PI3K inhibitor	Phase 1/Phase 2	RMM-GWAS	GCST90090980
392	MTOR	SB-2343	mTOR inhibitor|PI3K inhibitor	Phase 1	RMM-GWAS	GCST90090980
393	MTOR	sirolimus	mTOR inhibitor	Launched	RMM-GWAS	GCST90090980
394	MTOR	temsirolimus	mTOR inhibitor	Launched	RMM-GWAS	GCST90090980
395	MTOR	torin-1	mTOR inhibitor	Preclinical	RMM-GWAS	GCST90090980
396	MTOR	torin-2	mTOR inhibitor	Preclinical	RMM-GWAS	GCST90090980
397	MTOR	VE-822	ATR kinase inhibitor	Phase 2	RMM-GWAS	GCST90090980
398	MTOR	voxtalisib	mTOR inhibitor|PI3K inhibitor	Phase 2	RMM-GWAS	GCST90090980
399	MTOR	WAY-600	mTOR inhibitor	Preclinical	RMM-GWAS	GCST90090980
400	MTOR	WYE-125132	mTOR inhibitor	Preclinical	RMM-GWAS	GCST90090980
401	MTOR	WYE-354	mTOR inhibitor	Preclinical	RMM-GWAS	GCST90090980
402	MTOR	WYE-687	mTOR inhibitor	Preclinical	RMM-GWAS	GCST90090980
403	MTOR	XL388	mTOR inhibitor	Preclinical	RMM-GWAS	GCST90090980
404	ESR1	afimoxifene	estrogen receptor antagonist	Phase 2	RMM-GWAS	GCST90090980
405	ESR1	allylestrenol	steroidal progestin	Launched	RMM-GWAS	GCST90090980
406	ESR1	AZD9496	estrogen receptor agonist	Phase 1	RMM-GWAS	GCST90090980
407	ESR1	bazedoxifene	selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST90090980
408	ESR1	benfluralin		Phase 3	RMM-GWAS	GCST90090980
409	ESR1	bisphenol-A	synthetic estrogen	Phase 1	RMM-GWAS	GCST90090980
410	ESR1	bithionol	autotaxin inhibitor	Withdrawn	RMM-GWAS	GCST90090980
411	ESR1	chlorotrianisene	estrogenic hormone	Launched	RMM-GWAS	GCST90090980
412	ESR1	clomifene	estrogen receptor antagonist	Launched	RMM-GWAS	GCST90090980
413	ESR1	danazol	estrogen receptor antagonist|progesterone receptor agonist	Launched	RMM-GWAS	GCST90090980
414	ESR1	dehydroepiandrosterone	protein synthesis stimulant	Launched	RMM-GWAS	GCST90090980
415	ESR1	dehydroepiandrosterone-sulfate	androgen receptor agonist|estrogen receptor agonist	Launched	RMM-GWAS	GCST90090980
416	ESR1	desogestrel	progesterone receptor agonist	Launched	RMM-GWAS	GCST90090980
417	ESR1	dienestrol	estrogen receptor agonist	Launched	RMM-GWAS	GCST90090980
418	ESR1	diethylstilbestrol	estrogen receptor agonist	Withdrawn	RMM-GWAS	GCST90090980
419	ESR1	droloxifene	selective estrogen receptor modulator (SERM)	Phase 3	RMM-GWAS	GCST90090980
420	ESR1	endoxifen	estrogen receptor antagonist	Phase 2	RMM-GWAS	GCST90090980
421	ESR1	equol	estrogen receptor agonist	Launched	RMM-GWAS	GCST90090980
422	ESR1	erteberel	estrogen receptor agonist	Phase 2	RMM-GWAS	GCST90090980
423	ESR1	estetrol	selective estrogen receptor modulator (SERM)	Phase 3	RMM-GWAS	GCST90090980
424	ESR1	estradiol	estrogen receptor agonist	Launched	RMM-GWAS	GCST90090980
425	ESR1	estradiol-acetate	estrogen receptor agonist	Launched	RMM-GWAS	GCST90090980
426	ESR1	estradiol-benzoate	contraceptive agent	Preclinical	RMM-GWAS	GCST90090980
427	ESR1	estradiol-cypionate	estrogen receptor agonist	Launched	RMM-GWAS	GCST90090980
428	ESR1	estradiol-valerate	estrogen receptor agonist	Launched	RMM-GWAS	GCST90090980
429	ESR1	estramustine	DNA alkylating agent	Launched	RMM-GWAS	GCST90090980
430	ESR1	estramustine-phosphate	DNA synthesis inhibitor|microtubule inhibitor	Launched	RMM-GWAS	GCST90090980
431	ESR1	estriol	estrogen receptor agonist	Launched	RMM-GWAS	GCST90090980
432	ESR1	estrone	estrogen receptor agonist|estrogenic hormone	Launched	RMM-GWAS	GCST90090980
433	ESR1	estropipate	estrogen receptor agonist	Launched	RMM-GWAS	GCST90090980
434	ESR1	ethinyl-estradiol	estrogen receptor agonist|estrogenic hormone	Launched	RMM-GWAS	GCST90090980
435	ESR1	ethynodiol-diacetate		Launched	RMM-GWAS	GCST90090980
436	ESR1	etonogestrel	progesterone receptor agonist	Launched	RMM-GWAS	GCST90090980
437	ESR1	fosfestrol	synthetic estrogen	Launched	RMM-GWAS	GCST90090980
438	ESR1	fulvestrant	estrogen receptor antagonist	Launched	RMM-GWAS	GCST90090980
439	ESR1	GDC-0810	selective estrogen receptor destabilizer	Phase 2	RMM-GWAS	GCST90090980
440	ESR1	genistein	tyrosine kinase inhibitor	Phase 2/Phase 3	RMM-GWAS	GCST90090980
441	ESR1	gestrinone	progesterone receptor antagonist	Launched	RMM-GWAS	GCST90090980
442	ESR1	hexestrol	synthetic estrogen	Launched	RMM-GWAS	GCST90090980
443	ESR1	lasofoxifene	selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST90090980
444	ESR1	medroxyprogesterone-acetate	progesterone receptor agonist	Launched	RMM-GWAS	GCST90090980
445	ESR1	melatonin	melatonin receptor agonist|nitric oxide synthase inhibitor	Launched	RMM-GWAS	GCST90090980
446	ESR1	mestranol	estrogen receptor agonist	Launched	RMM-GWAS	GCST90090980
447	ESR1	mitotane	antineoplastic agent	Launched	RMM-GWAS	GCST90090980
448	ESR1	naloxone	opioid receptor antagonist	Launched	RMM-GWAS	GCST90090980
449	ESR1	norgestimate	progesterone receptor agonist	Launched	RMM-GWAS	GCST90090980
450	ESR1	norgestrel	progesterone receptor agonist	Launched	RMM-GWAS	GCST90090980
451	ESR1	ospemifene	selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST90090980
452	ESR1	PPT	estrogen receptor agonist	Preclinical	RMM-GWAS	GCST90090980
453	ESR1	progesterone	progesterone receptor agonist	Launched	RMM-GWAS	GCST90090980
454	ESR1	promestriene	estrogen receptor agonist	Launched	RMM-GWAS	GCST90090980
455	ESR1	quinestrol	estrogen receptor agonist	Launched	RMM-GWAS	GCST90090980
456	ESR1	raloxifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST90090980
457	ESR1	SNG-1153	selective estrogen receptor modulator (SERM)	Preclinical	RMM-GWAS	GCST90090980
458	ESR1	tamoxifen	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST90090980
459	ESR1	tibolone	androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist	Launched	RMM-GWAS	GCST90090980
460	ESR1	toremifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST90090980
461	ESR1	Y-134	estrogen receptor antagonist	Preclinical	RMM-GWAS	GCST90090980
462	ESR1	ZK-164015	estrogen receptor antagonist	Preclinical	RMM-GWAS	GCST90090980
463	ESR1	17-hydroxyprogesterone-caproate	progesterone receptor agonist	Launched	RMM-GWAS	GCST90090980
464	RRM2	cladribine	adenosine deaminase inhibitor|ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST90090980
465	RRM2	clofarabine	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST90090980
466	RRM2	fludarabine	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST90090980
467	RRM2	fludarabine-phosphate	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST90090980
468	RRM2	gemcitabine	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST90090980
469	RRM2	hydroxyurea	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST90090980
470	RRM2	triapine	ribonucleotide reductase inhibitor	Phase 2	RMM-GWAS	GCST90090980
471	MTOR	AP1903		Phase 1/Phase 2	RMM-GWAS	GCST006085
472	MTOR	AZD2014	mTOR inhibitor	Phase 2	RMM-GWAS	GCST006085
473	MTOR	AZD8055	mTOR inhibitor	Phase 1	RMM-GWAS	GCST006085
474	MTOR	AZ20	ATR kinase inhibitor	Preclinical	RMM-GWAS	GCST006085
475	MTOR	beta-hydroxy-beta-methylbutyrate	protein synthesis stimulant	Launched	RMM-GWAS	GCST006085
476	MTOR	BGT226	PI3K inhibitor	Phase 1/Phase 2	RMM-GWAS	GCST006085
477	MTOR	CC-115	DNA protein kinase inhibitor|mTOR inhibitor	Phase 2	RMM-GWAS	GCST006085
478	MTOR	CC-223	mTOR inhibitor	Phase 2	RMM-GWAS	GCST006085
479	MTOR	chrysophanic-acid	EGFR inhibitor	Preclinical	RMM-GWAS	GCST006085
480	MTOR	CH5132799	PI3K inhibitor	Phase 1	RMM-GWAS	GCST006085
481	MTOR	compound-401	DNA dependent protein kinase inhibitor	Preclinical	RMM-GWAS	GCST006085
482	MTOR	deforolimus	mTOR inhibitor	Phase 3	RMM-GWAS	GCST006085
483	MTOR	everolimus	mTOR inhibitor	Launched	RMM-GWAS	GCST006085
484	MTOR	GDC-0980	mTOR inhibitor|PI3K inhibitor	Phase 2	RMM-GWAS	GCST006085
485	MTOR	GSK2126458	mTOR inhibitor|PI3K inhibitor	Phase 1	RMM-GWAS	GCST006085
486	MTOR	KU-0063794	mTOR inhibitor	Preclinical	RMM-GWAS	GCST006085
487	MTOR	LY294002	DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor	Preclinical	RMM-GWAS	GCST006085
488	MTOR	LY3023414	mTOR inhibitor|PI3K inhibitor	Phase 2	RMM-GWAS	GCST006085
489	MTOR	MLN0128	mTOR inhibitor	Phase 2	RMM-GWAS	GCST006085
490	MTOR	NVP-BEZ235	mTOR inhibitor|PI3K inhibitor	Phase 3	RMM-GWAS	GCST006085
491	MTOR	OSI-027	mTOR inhibitor	Phase 1	RMM-GWAS	GCST006085
492	MTOR	palomid-529	AKT inhibitor|mTOR inhibitor	Phase 1	RMM-GWAS	GCST006085
493	MTOR	PF-04691502	mTOR inhibitor|PI3K inhibitor	Phase 2	RMM-GWAS	GCST006085
494	MTOR	PF-05212384	mTOR inhibitor|PI3K inhibitor	Phase 2	RMM-GWAS	GCST006085
495	MTOR	PI-103	mTOR inhibitor|PI3K inhibitor	Preclinical	RMM-GWAS	GCST006085
496	MTOR	PKI-179	mTOR inhibitor|PI3K inhibitor	Phase 1	RMM-GWAS	GCST006085
497	MTOR	PP-121	protein tyrosine kinase inhibitor	Preclinical	RMM-GWAS	GCST006085
498	MTOR	PP242	mTOR inhibitor	Preclinical	RMM-GWAS	GCST006085
499	MTOR	SAR-245409	PI3K inhibitor	Phase 1/Phase 2	RMM-GWAS	GCST006085
500	MTOR	SB-2343	mTOR inhibitor|PI3K inhibitor	Phase 1	RMM-GWAS	GCST006085
501	MTOR	sirolimus	mTOR inhibitor	Launched	RMM-GWAS	GCST006085
502	MTOR	temsirolimus	mTOR inhibitor	Launched	RMM-GWAS	GCST006085
503	MTOR	torin-1	mTOR inhibitor	Preclinical	RMM-GWAS	GCST006085
504	MTOR	torin-2	mTOR inhibitor	Preclinical	RMM-GWAS	GCST006085
505	MTOR	VE-822	ATR kinase inhibitor	Phase 2	RMM-GWAS	GCST006085
506	MTOR	voxtalisib	mTOR inhibitor|PI3K inhibitor	Phase 2	RMM-GWAS	GCST006085
507	MTOR	WAY-600	mTOR inhibitor	Preclinical	RMM-GWAS	GCST006085
508	MTOR	WYE-125132	mTOR inhibitor	Preclinical	RMM-GWAS	GCST006085
509	MTOR	WYE-354	mTOR inhibitor	Preclinical	RMM-GWAS	GCST006085
510	MTOR	WYE-687	mTOR inhibitor	Preclinical	RMM-GWAS	GCST006085
511	MTOR	XL388	mTOR inhibitor	Preclinical	RMM-GWAS	GCST006085
512	RRM2	cladribine	adenosine deaminase inhibitor|ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST006085
513	RRM2	clofarabine	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST006085
514	RRM2	fludarabine	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST006085
515	RRM2	fludarabine-phosphate	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST006085
516	RRM2	gemcitabine	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST006085
517	RRM2	hydroxyurea	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST006085
518	RRM2	triapine	ribonucleotide reductase inhibitor	Phase 2	RMM-GWAS	GCST006085
519	MAP2K1	arctigenin	MEK inhibitor	Preclinical	SIGMOID	GCST006085
520	MAP2K1	AS-703026	MEK inhibitor	Phase 2	SIGMOID	GCST006085
521	MAP2K1	BI-847325	Aurora kinase inhibitor|MEK inhibitor	Phase 1	SIGMOID	GCST006085
522	MAP2K1	binimetinib	MEK inhibitor	Launched	SIGMOID	GCST006085
523	MAP2K1	bosutinib	Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor	Launched	SIGMOID	GCST006085
524	MAP2K1	cobimetinib	MEK inhibitor	Launched	SIGMOID	GCST006085
525	MAP2K1	nobiletin	MEK inhibitor	Preclinical	SIGMOID	GCST006085
526	MAP2K1	PD-0325901	MEK inhibitor	Phase 2	SIGMOID	GCST006085
527	MAP2K1	PD-184352	MEK inhibitor	Phase 2	SIGMOID	GCST006085
528	MAP2K1	PD-198306	MAP kinase inhibitor|MEK inhibitor	Preclinical	SIGMOID	GCST006085
529	MAP2K1	PD-98059	MEK inhibitor	Preclinical	SIGMOID	GCST006085
530	MAP2K1	refametinib	MEK inhibitor	Phase 2	SIGMOID	GCST006085
531	MAP2K1	reversine	Aurora kinase inhibitor	Preclinical	SIGMOID	GCST006085
532	MAP2K1	Ro-4987655	MEK inhibitor	Phase 1	SIGMOID	GCST006085
533	MAP2K1	Ro-5126766	MEK inhibitor|RAF inhibitor	Phase 1	SIGMOID	GCST006085
534	MAP2K1	selumetinib	MEK inhibitor	Phase 3	SIGMOID	GCST006085
535	MAP2K1	TAK-733	MEK inhibitor	Phase 1	SIGMOID	GCST006085
536	MAP2K1	trametinib	MEK inhibitor	Launched	SIGMOID	GCST006085
537	MAP2K1	U-0126	MEK inhibitor	Preclinical	SIGMOID	GCST006085
538	MAP2K1	4,5,6,7-tetrabromobenzotriazole	casein kinase inhibitor	Preclinical	SIGMOID	GCST006085
539	AR	andarine	androgen receptor modulator	Phase 1	DOMINO	GCST011049
540	AR	APC-100	androgen receptor antagonist|anti-inflammatory agent	Phase 1/Phase 2	DOMINO	GCST011049
541	AR	apigenin	casein kinase inhibitor|cell proliferation inhibitor	Preclinical	DOMINO	GCST011049
542	AR	ASC-J9	androgen receptor enhancer	Phase 2	DOMINO	GCST011049
543	AR	AZD3514	androgen receptor modulator	Phase 1	DOMINO	GCST011049
544	AR	bicalutamide	androgen receptor antagonist	Launched	DOMINO	GCST011049
545	AR	bisphenol-A	synthetic estrogen	Phase 1	DOMINO	GCST011049
546	AR	CB-03-01	androgen receptor antagonist	Phase 3	DOMINO	GCST011049
547	AR	cortodoxone	androgen receptor antagonist	Phase 3	DOMINO	GCST011049
548	AR	cyproterone-acetate	androgen receptor antagonist	Launched	DOMINO	GCST011049
549	AR	danazol	estrogen receptor antagonist|progesterone receptor agonist	Launched	DOMINO	GCST011049
550	AR	darolutamide	androgen receptor antagonist	Launched	DOMINO	GCST011049
551	AR	dehydroepiandrosterone-sulfate	androgen receptor agonist|estrogen receptor agonist	Launched	DOMINO	GCST011049
552	AR	dromostanolone-propionate	androgen receptor modulator	Launched	DOMINO	GCST011049
553	AR	drospirenone	mineralocorticoid receptor antagonist	Launched	DOMINO	GCST011049
554	AR	enzalutamide	androgen receptor antagonist	Launched	DOMINO	GCST011049
555	AR	epitiostanol	androgen receptor agonist	Launched	DOMINO	GCST011049
556	AR	eugenol	androgen receptor antagonist	Launched	DOMINO	GCST011049
557	AR	flufenamic-acid	chloride channel blocker	Preclinical	DOMINO	GCST011049
558	AR	flutamide	androgen receptor antagonist	Launched	DOMINO	GCST011049
559	AR	galeterone	androgen receptor modulator	Phase 3	DOMINO	GCST011049
560	AR	gestrinone	progesterone receptor antagonist	Launched	DOMINO	GCST011049
561	AR	GLPG0492	androgen receptor modulator	Phase 1	DOMINO	GCST011049
562	AR	GLPG0492-R-enantiomer	androgen receptor modulator	Phase 1	DOMINO	GCST011049
563	AR	kaempferol	bone resorption inhibitor|estrogen-related receptor inverse agonist	Preclinical	DOMINO	GCST011049
564	AR	LXR-623	LXR agonist	Phase 1	DOMINO	GCST011049
565	AR	LY2452473	androgen receptor modulator	Phase 2	DOMINO	GCST011049
566	AR	mifepristone	glucocorticoid receptor antagonist|progesterone receptor antagonist	Launched	DOMINO	GCST011049
567	AR	MK-0773	androgen receptor modulator	Phase 2	DOMINO	GCST011049
568	AR	nilutamide	androgen receptor antagonist	Launched	DOMINO	GCST011049
569	AR	norgestrel	progesterone receptor agonist	Launched	DOMINO	GCST011049
570	AR	ostarine	androgen receptor modulator	Phase 3	DOMINO	GCST011049
571	AR	PS178990	androgen receptor modulator	Phase 1	DOMINO	GCST011049
572	AR	pyrvinium-pamoate	androgen receptor antagonist	Launched	DOMINO	GCST011049
573	AR	RU-58841	androgen receptor antagonist	Phase 2	DOMINO	GCST011049
574	AR	spironolactone	mineralocorticoid receptor antagonist	Launched	DOMINO	GCST011049
575	AR	17-hydroxyprogesterone-caproate	progesterone receptor agonist	Launched	DOMINO	GCST011049
576	AR	2-hydroxyflutamide	androgen receptor antagonist	Phase 2	DOMINO	GCST011049
577	AR	3,3'-diindolylmethane	CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor	Phase 3	DOMINO	GCST011049
578	MTOR	AP1903		Phase 1/Phase 2	RMM-GWAS	GCST011049
579	MTOR	AZD2014	mTOR inhibitor	Phase 2	RMM-GWAS	GCST011049
580	MTOR	AZD8055	mTOR inhibitor	Phase 1	RMM-GWAS	GCST011049
581	MTOR	AZ20	ATR kinase inhibitor	Preclinical	RMM-GWAS	GCST011049
582	MTOR	beta-hydroxy-beta-methylbutyrate	protein synthesis stimulant	Launched	RMM-GWAS	GCST011049
583	MTOR	BGT226	PI3K inhibitor	Phase 1/Phase 2	RMM-GWAS	GCST011049
584	MTOR	CC-115	DNA protein kinase inhibitor|mTOR inhibitor	Phase 2	RMM-GWAS	GCST011049
585	MTOR	CC-223	mTOR inhibitor	Phase 2	RMM-GWAS	GCST011049
586	MTOR	chrysophanic-acid	EGFR inhibitor	Preclinical	RMM-GWAS	GCST011049
587	MTOR	CH5132799	PI3K inhibitor	Phase 1	RMM-GWAS	GCST011049
588	MTOR	compound-401	DNA dependent protein kinase inhibitor	Preclinical	RMM-GWAS	GCST011049
589	MTOR	deforolimus	mTOR inhibitor	Phase 3	RMM-GWAS	GCST011049
590	MTOR	everolimus	mTOR inhibitor	Launched	RMM-GWAS	GCST011049
591	MTOR	GDC-0980	mTOR inhibitor|PI3K inhibitor	Phase 2	RMM-GWAS	GCST011049
592	MTOR	GSK2126458	mTOR inhibitor|PI3K inhibitor	Phase 1	RMM-GWAS	GCST011049
593	MTOR	KU-0063794	mTOR inhibitor	Preclinical	RMM-GWAS	GCST011049
594	MTOR	LY294002	DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor	Preclinical	RMM-GWAS	GCST011049
595	MTOR	LY3023414	mTOR inhibitor|PI3K inhibitor	Phase 2	RMM-GWAS	GCST011049
596	MTOR	MLN0128	mTOR inhibitor	Phase 2	RMM-GWAS	GCST011049
597	MTOR	NVP-BEZ235	mTOR inhibitor|PI3K inhibitor	Phase 3	RMM-GWAS	GCST011049
598	MTOR	OSI-027	mTOR inhibitor	Phase 1	RMM-GWAS	GCST011049
599	MTOR	palomid-529	AKT inhibitor|mTOR inhibitor	Phase 1	RMM-GWAS	GCST011049
600	MTOR	PF-04691502	mTOR inhibitor|PI3K inhibitor	Phase 2	RMM-GWAS	GCST011049
601	MTOR	PF-05212384	mTOR inhibitor|PI3K inhibitor	Phase 2	RMM-GWAS	GCST011049
602	MTOR	PI-103	mTOR inhibitor|PI3K inhibitor	Preclinical	RMM-GWAS	GCST011049
603	MTOR	PKI-179	mTOR inhibitor|PI3K inhibitor	Phase 1	RMM-GWAS	GCST011049
604	MTOR	PP-121	protein tyrosine kinase inhibitor	Preclinical	RMM-GWAS	GCST011049
605	MTOR	PP242	mTOR inhibitor	Preclinical	RMM-GWAS	GCST011049
606	MTOR	SAR-245409	PI3K inhibitor	Phase 1/Phase 2	RMM-GWAS	GCST011049
607	MTOR	SB-2343	mTOR inhibitor|PI3K inhibitor	Phase 1	RMM-GWAS	GCST011049
608	MTOR	sirolimus	mTOR inhibitor	Launched	RMM-GWAS	GCST011049
609	MTOR	temsirolimus	mTOR inhibitor	Launched	RMM-GWAS	GCST011049
610	MTOR	torin-1	mTOR inhibitor	Preclinical	RMM-GWAS	GCST011049
611	MTOR	torin-2	mTOR inhibitor	Preclinical	RMM-GWAS	GCST011049
612	MTOR	VE-822	ATR kinase inhibitor	Phase 2	RMM-GWAS	GCST011049
613	MTOR	voxtalisib	mTOR inhibitor|PI3K inhibitor	Phase 2	RMM-GWAS	GCST011049
614	MTOR	WAY-600	mTOR inhibitor	Preclinical	RMM-GWAS	GCST011049
615	MTOR	WYE-125132	mTOR inhibitor	Preclinical	RMM-GWAS	GCST011049
616	MTOR	WYE-354	mTOR inhibitor	Preclinical	RMM-GWAS	GCST011049
617	MTOR	WYE-687	mTOR inhibitor	Preclinical	RMM-GWAS	GCST011049
618	MTOR	XL388	mTOR inhibitor	Preclinical	RMM-GWAS	GCST011049
619	POLR2A	dactinomycin	RNA polymerase inhibitor	Launched	RMM-GWAS	GCST011049
620	RRM2	cladribine	adenosine deaminase inhibitor|ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST011049
621	RRM2	clofarabine	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST011049
622	RRM2	fludarabine	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST011049
623	RRM2	fludarabine-phosphate	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST011049
624	RRM2	gemcitabine	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST011049
625	RRM2	hydroxyurea	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST011049
626	RRM2	triapine	ribonucleotide reductase inhibitor	Phase 2	RMM-GWAS	GCST011049
627	AR	andarine	androgen receptor modulator	Phase 1	SIGMOID	GCST011049
628	AR	APC-100	androgen receptor antagonist|anti-inflammatory agent	Phase 1/Phase 2	SIGMOID	GCST011049
629	AR	apigenin	casein kinase inhibitor|cell proliferation inhibitor	Preclinical	SIGMOID	GCST011049
630	AR	ASC-J9	androgen receptor enhancer	Phase 2	SIGMOID	GCST011049
631	AR	AZD3514	androgen receptor modulator	Phase 1	SIGMOID	GCST011049
632	AR	bicalutamide	androgen receptor antagonist	Launched	SIGMOID	GCST011049
633	AR	bisphenol-A	synthetic estrogen	Phase 1	SIGMOID	GCST011049
634	AR	CB-03-01	androgen receptor antagonist	Phase 3	SIGMOID	GCST011049
635	AR	cortodoxone	androgen receptor antagonist	Phase 3	SIGMOID	GCST011049
636	AR	cyproterone-acetate	androgen receptor antagonist	Launched	SIGMOID	GCST011049
637	AR	danazol	estrogen receptor antagonist|progesterone receptor agonist	Launched	SIGMOID	GCST011049
638	AR	darolutamide	androgen receptor antagonist	Launched	SIGMOID	GCST011049
639	AR	dehydroepiandrosterone-sulfate	androgen receptor agonist|estrogen receptor agonist	Launched	SIGMOID	GCST011049
640	AR	dromostanolone-propionate	androgen receptor modulator	Launched	SIGMOID	GCST011049
641	AR	drospirenone	mineralocorticoid receptor antagonist	Launched	SIGMOID	GCST011049
642	AR	enzalutamide	androgen receptor antagonist	Launched	SIGMOID	GCST011049
643	AR	epitiostanol	androgen receptor agonist	Launched	SIGMOID	GCST011049
644	AR	eugenol	androgen receptor antagonist	Launched	SIGMOID	GCST011049
645	AR	flufenamic-acid	chloride channel blocker	Preclinical	SIGMOID	GCST011049
646	AR	flutamide	androgen receptor antagonist	Launched	SIGMOID	GCST011049
647	AR	galeterone	androgen receptor modulator	Phase 3	SIGMOID	GCST011049
648	AR	gestrinone	progesterone receptor antagonist	Launched	SIGMOID	GCST011049
649	AR	GLPG0492	androgen receptor modulator	Phase 1	SIGMOID	GCST011049
650	AR	GLPG0492-R-enantiomer	androgen receptor modulator	Phase 1	SIGMOID	GCST011049
651	AR	kaempferol	bone resorption inhibitor|estrogen-related receptor inverse agonist	Preclinical	SIGMOID	GCST011049
652	AR	LXR-623	LXR agonist	Phase 1	SIGMOID	GCST011049
653	AR	LY2452473	androgen receptor modulator	Phase 2	SIGMOID	GCST011049
654	AR	mifepristone	glucocorticoid receptor antagonist|progesterone receptor antagonist	Launched	SIGMOID	GCST011049
655	AR	MK-0773	androgen receptor modulator	Phase 2	SIGMOID	GCST011049
656	AR	nilutamide	androgen receptor antagonist	Launched	SIGMOID	GCST011049
657	AR	norgestrel	progesterone receptor agonist	Launched	SIGMOID	GCST011049
658	AR	ostarine	androgen receptor modulator	Phase 3	SIGMOID	GCST011049
659	AR	PS178990	androgen receptor modulator	Phase 1	SIGMOID	GCST011049
660	AR	pyrvinium-pamoate	androgen receptor antagonist	Launched	SIGMOID	GCST011049
661	AR	RU-58841	androgen receptor antagonist	Phase 2	SIGMOID	GCST011049
662	AR	spironolactone	mineralocorticoid receptor antagonist	Launched	SIGMOID	GCST011049
663	AR	17-hydroxyprogesterone-caproate	progesterone receptor agonist	Launched	SIGMOID	GCST011049
664	AR	2-hydroxyflutamide	androgen receptor antagonist	Phase 2	SIGMOID	GCST011049
665	AR	3,3'-diindolylmethane	CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor	Phase 3	SIGMOID	GCST011049
666	CHD1	epirubicin	topoisomerase inhibitor	Launched	DOMINO	GCST007856
667	CHD1	epirubicin	topoisomerase inhibitor	Launched	RMM-GWAS	GCST007856
668	MAP2	docetaxel	tubulin polymerization inhibitor	Launched	RMM-GWAS	GCST007728
669	MAP2	estramustine	DNA alkylating agent	Launched	RMM-GWAS	GCST007728
670	MAP2	estramustine-phosphate	DNA synthesis inhibitor|microtubule inhibitor	Launched	RMM-GWAS	GCST007728
671	MAP2	paclitaxel	tubulin polymerization inhibitor	Launched	RMM-GWAS	GCST007728
672	HRH1	ABT-239	histamine receptor antagonist	Phase 1	RMM-GWAS	GCST007692
673	HRH1	acrivastine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
674	HRH1	alcaftadine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
675	HRH1	alimemazine	histamine receptor agonist|histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
676	HRH1	amitriptyline	norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	Launched	RMM-GWAS	GCST007692
677	HRH1	amoxapine	norepinephrine reputake inhibitor	Launched	RMM-GWAS	GCST007692
678	HRH1	antazoline	antihistamine	Launched	RMM-GWAS	GCST007692
679	HRH1	aripiprazole	serotonin receptor agonist|serotonin receptor antagonist	Launched	RMM-GWAS	GCST007692
680	HRH1	asenapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	RMM-GWAS	GCST007692
681	HRH1	astemizole	histamine receptor antagonist	Withdrawn	RMM-GWAS	GCST007692
682	HRH1	azacyclonol	histamine receptor antagonist	Preclinical	RMM-GWAS	GCST007692
683	HRH1	azatadine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
684	HRH1	azelastine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
685	HRH1	benztropine-mesylate	acetylcholine receptor antagonist	Launched	RMM-GWAS	GCST007692
686	HRH1	bepotastine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
687	HRH1	betahistine	histamine receptor agonist|histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
688	HRH1	bilastine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
689	HRH1	brompheniramine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
690	HRH1	buclizine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
691	HRH1	carbinoxamine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
692	HRH1	carebastine	histamine receptor antagonist	Phase 1	RMM-GWAS	GCST007692
693	HRH1	cetirizine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
694	HRH1	chloropyramine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
695	HRH1	chlorpromazine	dopamine receptor antagonist	Launched	RMM-GWAS	GCST007692
696	HRH1	chlorprothixene	dopamine receptor antagonist	Launched	RMM-GWAS	GCST007692
697	HRH1	citalopram	selective serotonin reuptake inhibitor (SSRI)	Launched	RMM-GWAS	GCST007692
698	HRH1	clemastine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
699	HRH1	clobenpropit	histamine receptor antagonist	Preclinical	RMM-GWAS	GCST007692
700	HRH1	clofedanol	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
701	HRH1	clorotepine	adrenergic receptor antagonist|dopamine receptor antagonist	Launched	RMM-GWAS	GCST007692
702	HRH1	clozapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	RMM-GWAS	GCST007692
703	HRH1	cyclizine	histamine receptor modulator	Launched	RMM-GWAS	GCST007692
704	HRH1	cyproheptadine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
705	HRH1	deptropine	histamine receptor antagonist	Preclinical	RMM-GWAS	GCST007692
706	HRH1	desipramine	tricyclic antidepressant	Launched	RMM-GWAS	GCST007692
707	HRH1	desloratadine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
708	HRH1	dimenhydrinate	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
709	HRH1	dimethindene-(S)-(+)	acetylcholine receptor antagonist	Preclinical	RMM-GWAS	GCST007692
710	HRH1	dimetindene	cholinergic receptor antagonist|histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
711	HRH1	diphenhydramine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
712	HRH1	diphenylpyraline	dopamine reuptake inhibitor	Launched	RMM-GWAS	GCST007692
713	HRH1	dosulepin	norepinephrine reuptake inhibitor|serotoninâ€“norepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant	Launched	RMM-GWAS	GCST007692
714	HRH1	doxepin	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
715	HRH1	doxylamine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
716	HRH1	DPPE	histamine receptor antagonist	Phase 3	RMM-GWAS	GCST007692
717	HRH1	ebastine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
718	HRH1	emedastine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
719	HRH1	epinastine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
720	HRH1	fexofenadine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
721	HRH1	flunarizine	calcium channel blocker	Launched	RMM-GWAS	GCST007692
722	HRH1	fluphenazine	dopamine receptor antagonist	Launched	RMM-GWAS	GCST007692
723	HRH1	fluspirilene	dopamine receptor antagonist	Launched	RMM-GWAS	GCST007692
724	HRH1	haloperidol	dopamine receptor antagonist	Launched	RMM-GWAS	GCST007692
725	HRH1	histamine	histamine receptor agonist	Launched	RMM-GWAS	GCST007692
726	HRH1	homochlorcyclizine	antihistamine	Launched	RMM-GWAS	GCST007692
727	HRH1	hydroxyzine	antihistamine	Launched	RMM-GWAS	GCST007692
728	HRH1	iloperidone	dopamine receptor antagonist|serotonin receptor antagonist	Launched	RMM-GWAS	GCST007692
729	HRH1	imipramine	norepinephrine reputake inhibitor|serotonin reuptake inhibitor	Launched	RMM-GWAS	GCST007692
730	HRH1	ketotifen	histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor	Launched	RMM-GWAS	GCST007692
731	HRH1	latrepirdine	glutamate receptor antagonist	Phase 3	RMM-GWAS	GCST007692
732	HRH1	levocabastine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
733	HRH1	levocetirizine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
734	HRH1	levomepromazine	dopamine receptor antagonist	Launched	RMM-GWAS	GCST007692
735	HRH1	levomequitazine	histamine receptor antagonist	Phase 2	RMM-GWAS	GCST007692
736	HRH1	loratadine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
737	HRH1	loxapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	RMM-GWAS	GCST007692
738	HRH1	mepyramine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
739	HRH1	methapyrilene	histamine receptor antagonist	Withdrawn	RMM-GWAS	GCST007692
740	HRH1	mianserin	serotonin receptor antagonist	Launched	RMM-GWAS	GCST007692
741	HRH1	mizolastine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
742	HRH1	molindone	dopamine receptor antagonist	Launched	RMM-GWAS	GCST007692
743	HRH1	nortriptyline	tricyclic antidepressant	Launched	RMM-GWAS	GCST007692
744	HRH1	olanzapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	RMM-GWAS	GCST007692
745	HRH1	olopatadine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
746	HRH1	oxatomide	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
747	HRH1	pemirolast	mediator release inhibitor	Launched	RMM-GWAS	GCST007692
748	HRH1	perphenazine	dopamine receptor antagonist	Launched	RMM-GWAS	GCST007692
749	HRH1	phenindamine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
750	HRH1	pheniramine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
751	HRH1	pimozide	dopamine receptor antagonist	Launched	RMM-GWAS	GCST007692
752	HRH1	pipamperone	dopamine receptor antagonist	Launched	RMM-GWAS	GCST007692
753	HRH1	promazine	dopamine receptor antagonist	Launched	RMM-GWAS	GCST007692
754	HRH1	promethazine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
755	HRH1	quetiapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	RMM-GWAS	GCST007692
756	HRH1	risperidone	dopamine receptor antagonist|serotonin receptor antagonist	Launched	RMM-GWAS	GCST007692
757	HRH1	rupatadine	histamine receptor antagonist|platelet activating factor receptor antagonist	Launched	RMM-GWAS	GCST007692
758	HRH1	sertindole	dopamine receptor antagonist|serotonin receptor antagonist	Withdrawn	RMM-GWAS	GCST007692
759	HRH1	setiptiline	adrenergic receptor antagonist	Launched	RMM-GWAS	GCST007692
760	HRH1	terfenadine	histamine receptor antagonist	Withdrawn	RMM-GWAS	GCST007692
761	HRH1	thioridazine	dopamine receptor antagonist	Withdrawn	RMM-GWAS	GCST007692
762	HRH1	thiothixene	dopamine receptor antagonist	Launched	RMM-GWAS	GCST007692
763	HRH1	tolazoline	adrenergic receptor antagonist	Launched	RMM-GWAS	GCST007692
764	HRH1	tranilast	angiogenesis inhibitor	Launched	RMM-GWAS	GCST007692
765	HRH1	trazodone	adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor	Launched	RMM-GWAS	GCST007692
766	HRH1	trifluoperazine	dopamine receptor antagonist	Launched	RMM-GWAS	GCST007692
767	HRH1	tripelennamine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
768	HRH1	triprolidine	histamine receptor antagonist	Launched	RMM-GWAS	GCST007692
769	HRH1	vilazodone	serotonin reuptake inhibitor	Launched	RMM-GWAS	GCST007692
770	HRH1	ziprasidone	dopamine receptor antagonist|serotonin receptor antagonist	Launched	RMM-GWAS	GCST007692
771	HRH1	zotepine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	RMM-GWAS	GCST007692
772	HRH1	zuclopenthixol	dopamine receptor antagonist	Launched	RMM-GWAS	GCST007692
773	HRH1	2-pyridylethylamine	histamine receptor agonist	Preclinical	RMM-GWAS	GCST007692
